High Tech Pharm Co Ltd banner
H

High Tech Pharm Co Ltd
KOSDAQ:106190

Watchlist Manager
High Tech Pharm Co Ltd
KOSDAQ:106190
Watchlist
Price: 15 800 KRW -1.8% Market Closed
Market Cap: ₩168B

Profitability Summary

High Tech Pharm Co Ltd's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

Margins

Earnings Waterfall
High Tech Pharm Co Ltd

Margins Comparison
High Tech Pharm Co Ltd Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
KR
High Tech Pharm Co Ltd
KOSDAQ:106190
168B KRW
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
987.9B USD
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
596.5B USD
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
293B CHF
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
249.7B CHF
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
240.5B GBP
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
307.4B USD
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.1T DKK
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
156.9B USD
Loading...
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
125.6B USD
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
High Tech Pharm Co Ltd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
KR
High Tech Pharm Co Ltd
KOSDAQ:106190
168B KRW
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
987.9B USD
Loading...
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
596.5B USD
Loading...
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
293B CHF
Loading...
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
249.7B CHF
Loading...
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
240.5B GBP
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
307.4B USD
Loading...
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.1T DKK
Loading...
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
156.9B USD
Loading...
Loading...
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
125.6B USD
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
High Tech Pharm Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett